CLIENT NEWS
- Alacris Theranostics schließt Crowdfunding-Kampagne bei Seedmatch erfolgreich ab18 February 2019
- NOXXON publishes a shareholder letter18 February 2019
- Motif Bio plc: Motif BioSciences Enters into Amendment Agreement with Hercules Capital18 February 2019
- InflaRx N.V.: Richard Brudnick to join InflaRx Board of Directors14 February 2019
- BIO-Europe Spring® comes to Vienna for Europe’s most important springtime life science partnering event14 February 2019
- Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO11 February 2019
- Adrenomed AG announces publication of Phase II trial design of Adrecizumab to treat septic shock07 February 2019
- InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa06 February 2019
- MagForce AG: Newly launched ’NanoTherm® Therapy School’ kicks off with successful first training session06 February 2019
- MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.05 February 2019